Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.

Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide. Circulation. 2002 Sep 17; 106(12):1470-6.

View in: PubMed

subject areas

Acute Disease
Aged
Amino Acid Chloromethyl Ketones
Angina, Unstable
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal
Anticoagulants
Citric Acid
Coronary Disease
Female
Humans
Immunoglobulin Fab Fragments
Kinetics
Male
Middle Aged
Myocardial Infarction
Peptides
Platelet Aggregation
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Syndrome
Tyrosine

authors with profiles

Robert Harrington